These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8039099)

  • 1. Anatomic and physiologic imaging of Alzheimer's disease.
    Giacometti AR; Davis PC; Alazraki NP; Malko JA
    Clin Geriatr Med; 1994 May; 10(2):277-98. PubMed ID: 8039099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies.
    Devous MD
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1685-96. PubMed ID: 12458405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future.
    Petrella JR; Coleman RE; Doraiswamy PM
    Radiology; 2003 Feb; 226(2):315-36. PubMed ID: 12563122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain in older persons with and without dementia: findings on MR, PET, and SPECT images.
    Davis PC; Mirra SS; Alazraki N
    AJR Am J Roentgenol; 1994 Jun; 162(6):1267-78. PubMed ID: 8191980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging.
    Fazekas F; Alavi A; Chawluk JB; Zimmerman RA; Hackney D; Bilaniuk L; Rosen M; Alves WM; Hurtig HI; Jamieson DG
    J Nucl Med; 1989 Oct; 30(10):1607-15. PubMed ID: 2795200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Alzheimer's disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy?
    Kubota T; Ushijima Y; Yamada K; Okuyama C; Kizu O; Nishimura T
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):414-21. PubMed ID: 15821961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of Alzheimer's disease.
    Lee BC; Mintun M; Buckner RL; Morris JC
    J Neuroimaging; 2003 Jul; 13(3):199-214. PubMed ID: 12889165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging in Alzheimer disease: an evidence-based review.
    Kantarci K; Jack CR
    Neuroimaging Clin N Am; 2003 May; 13(2):197-209. PubMed ID: 13677801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis of Alzheimer's disease: a question of image?
    Jobst KA; Hindley NJ; King E; Smith AD
    J Clin Psychiatry; 1994 Nov; 55 Suppl():22-31. PubMed ID: 7989291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel neuroimaging perspectives in the diagnosis of dementia].
    Jessen F
    Nervenarzt; 2008 Nov; 79 Suppl 3():129-36; quiz 137. PubMed ID: 18830576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evidence for neuroanatomic and neuropsychological markers in dementia of the Alzheimer's type.
    Zakzanis KK
    J Clin Exp Neuropsychol; 1998 Apr; 20(2):259-69. PubMed ID: 9777480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of 1H MR spectroscopy findings in Alzheimer's disease.
    Soher BJ; Doraiswamy PM; Charles HC
    Neuroimaging Clin N Am; 2005 Nov; 15(4):847-52, xi. PubMed ID: 16443495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neuroimaging in mild cognitive impairment.
    Matsuda H
    Neuropathology; 2007 Dec; 27(6):570-7. PubMed ID: 18021379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
    Arana E; Martínez-Granados B; Marti-Bonmati L; Martínez-Bisbal MC; Gil A; Blasco C; Celda B
    Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging criteria to identify the epileptic focus. Magnetic resonance imaging, magnetic resonance spectroscopy, positron emission tomography scanning, and single photon emission computed tomography.
    Laxer KD; Garcia PA
    Neurosurg Clin N Am; 1993 Apr; 4(2):199-209. PubMed ID: 8467206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
    Jones RS; Waldman AD
    Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of neuroimaging in dementia.
    DeCarli C
    Clin Geriatr Med; 2001 May; 17(2):255-79. PubMed ID: 11375135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting functional imaging tools (MRS, SPECT, PET and PCT).
    Van Der Naalt J
    Handb Clin Neurol; 2015; 127():295-308. PubMed ID: 25702224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI, CT, SPECT, PET: their use in diagnosing dementia.
    Jagust WJ; Eberling JL
    Geriatrics; 1991 Feb; 46(2):28-35. PubMed ID: 1991619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.